Fachliteratur Gastroenterologie: Neoplasien Oesophagus

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Oesophagus » Neoplasie

19. November 2025

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 1871


	Artikel 1 - 20 / 37419

	Continuing Medical Education Questions: November 2025. Am J Gastroenterol Inamdar S. PMID: 41257378 [PubMed - indexed for MEDLINE]
	Knowledge, attitudes, and practices of esophageal cancer patients regarding pulmonary rehabilitation training. Front Public Health Wang W, Xing W, Chen P, Sun H, Wang Z, Zheng Y, Yu Y, Zeng D. PMID: 41256272 [PubMed - indexed for MEDLINE]
	Development of a CTL Epitope-Based Vaccine Targeting Tumor Antigens in Esophageal Cancer: An Immunoinformatic Study. Iran J Biotechnol Cao H, Ding F. PMID: 41255832 [PubMed]
	Neoadjuvant Chemoimmunotherapy Combined With Node-Sparing Radiotherapy for Clinical T3N+ Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Single-Arm, Phase II Study (CINSREC Trial). Thorac Cancer Zhou X, Chen C, Zeng Y, Yang Z, Zhuo Y, Wang Y, Zhang L, Cai X, Guo X. PMID: 41255050 [PubMed - indexed for MEDLINE]
	Outcomes and predictive factors in post-surgical resection of sT4a esophageal cancer. World J Surg Oncol Wang M, Lv H, Chu Q, Gao W, Zhu Y, Xu Y, Wang Z, Tian Z. PMID: 41254673 [PubMed - indexed for MEDLINE]
	Unveiling the role of m6A modification in esophageal cancer: a new frontier in tumor innate interferon immunity. Cancer Cell Int Zuo X, Liu G, Guo J, Wang Y. PMID: 41254617 [PubMed]
	Comprehensive Evaluation of Lipids, Lipoproteins, and Metabolites Associated with Gastrointestinal Cancer Risk. Cancer Epidemiol Biomarkers Prev Sun M, Chen W, Cheng X, Cui H, Huang J, Huang R, Li Y, Ma Y, Hang D. PMID: 41252339 [PubMed - as supplied by publisher]
	Tislelizumabâ€‰+â€‰Chemotherapy in Gastric Cancer: Long-Term RATIONALE-305 Randomized Trial Follow-up. Adv Ther Cruz-Correa M, Oh DY, Kato K, Tabernero J, Bai Y, Shi J, Lee KW, Hirano H, Spigel D, Wyrwicz L, Pazo Cid R, Cubillo Gracián A, Xu Y, Sheng T, Yang S, Xu RH, Moehler M. PMID: 41251890 [PubMed - as supplied by publisher]
	Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study. Cancer Immunol Immunother Liu Q, Chen J, Xu Y, Shen W, Ye J, Luo H, Zhang X, Liu W, Xu Y, Zhang Y, Liu A, Li X, Ge H, Wang Q, Luo H, Zhao L, Xie C, Lin Q, Xie C, Xiong J, Chen W, Wang L, Zhao K. PMID: 41251846 [PubMed - indexed for MEDLINE]
	Induction chemotherapy followed by definitive chemoradiation in patients with inoperable esophageal squamous cell carcinoma: a multicenter retrospective study. Discov Oncol Sahin TK, Eroglu I, Dilli I, Sutcuoglu O, Chalabiyev E, Guven DC, Aktas BY, Kaya DM, Ates O, Ozdemir N, Yalcin S, Dizdar O. PMID: 41251837 [PubMed]
	MR outperformed CT in evaluating RECIST response to neoadjuvant therapy in locally advanced esophageal squamous cell carcinoma. Eur Radiol Li W, Wang Z, Wang Z, Dong Y, Chu F, Huang Y, Wang M, Darwish O, Nickel D, Zhao K, Zheng Y, Kamel IR, Qu J. PMID: 41251725 [PubMed - as supplied by publisher]
	Consolidative thoracic radiotherapy improves the prognosis of metastatic esophageal cancer in the chemoimmunotherapy era: a propensity score matching study. BMC Cancer Cui L, Yao N, Qin Z, Qin Q, Li N, Tong S, Pei Y, Yao Y. PMID: 41250071 [PubMed - in process]
	Multicancer early detection in a cohort of patients with confirmed and suspected cancer by measuring plasma amino acid cross sections with the Enlighten test: MODERNISED protocol. BMJ Open Wilding S, Goss V, Sukdao W, Hamady Z, Lord J, Coleman A, Pointer C, Walters J, Herbert W, Mclaughlin K, Waugh R, Irvine N, Oliver T, Soulsby I, Hooper J, Crabb SJ, Griffiths G, Yates E, Davies A. PMID: 41248417 [PubMed - indexed for MEDLINE]
	Oesophageal cancer and its associated factors among patients attending surgical and oncology clinics at Garissa County Referral Hospital, Kenya: a case-control study. BMJ Open Bashir A, Ngari M, Otieno B, Y'Dhidha-A-Mjidho M, Abdullahi O, Kariuki SM. PMID: 41248363 [PubMed - indexed for MEDLINE]
	Predictors of readmission after esophagectomy for esophageal cancer: a systematic review and meta-analysis. Int J Surg Khaw SP, Jabar H, Fong YB, Kueh MTW, Saxena K, Tan SH, Voon K. PMID: 41247924 [PubMed - as supplied by publisher]
	Anti-OLA1 autoantibody is a potential early diagnostic marker for hepatocellular carcinoma. Front Immunol Xiong W, Duan X, Dai L, Wang P, Ye H, Shi J, Wang K. PMID: 41246329 [PubMed - indexed for MEDLINE]
	Analysis of risk factors for anastomotic leakage after radical esophagectomy for esophageal squamous cell carcinoma. Front Med (Lausanne) Hu Q, Sun L, Xu S, Hong W, Tang L, Li F, Wang Y. PMID: 41244783 [PubMed]
	Design, synthesis, and biological evaluation of procaine-based triazole-isoxazoline hybrids as selective PI3K/mTOR inhibitors for esophageal cancer therapy: in vitro and in vivo studies. RSC Med Chem Sheng Y, Wu B, Li F, Zhang C. PMID: 41244753 [PubMed - as supplied by publisher]
	AI-Guided SERS Defines a Pan-Cancer Diagnostic Biomarker. Adv Sci (Weinh) Zhang C, Zhao WH, Zuo D, Zhou T, Hou W, Wang L, Shi S, Yang Y, Liu Y, Sun SK, Ren L, Ye Z, Liu D, Li D, Chen X, Hao J. PMID: 41243246 [PubMed - as supplied by publisher]
	Effectiveness of artificial intelligence-assisted examination for cancer detection in medical imaging: a systematic review and meta-analysis. J Am Coll Radiol Song J, Gao Y, Liu W, Sun X, Chen C, Wu IX. PMID: 41241061 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 37419

Seite 1 von 1871



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung